HEMOSHEAR THERAPEUTICS
HemoShear Therapeutics develops new treatments for patients with rare metabolic disorders. It creates human-relevant systems to accurately replicate the biology of organ systems and diseases for use throughout drug discovery and development. They work strategically in partnerships with pharmaceutical, biotechnology, and medical device companies. It generates meaningful human response data to increase confidence in decision-making, reduce the risk of costly failures, and identify efficacious therapies.
HEMOSHEAR THERAPEUTICS
Industry:
Biotechnology Health Care Medical
Founded:
2008-01-01
Address:
Charlottesville, Virginia, United States
Country:
United States
Website Url:
http://www.hemoshear.com
Total Employee:
11+
Status:
Active
Contact:
(434) 872-0196
Email Addresses:
[email protected]
Total Funding:
60.15 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Google Tag Manager Google Universal Analytics Domain Not Resolving Apache
Similar Organizations
Akebia Therapeutics
Akebia Therapeutics develops treatments for ischemia and vascular diseases.
Edison Pharmaceuticals
Edison Pharmaceuticals develops medicines for the treatments of children and adults diagnosed with rare and neglected diseases.
Neumora Therapeutics
Neumora Therapeutics operates as a clinical-stage biotechnology company.
Knopp Biosciences
Knopp Neurosciences is a drug discovery and development company working on treatments for neurological disorders.
PetMend
Veterinary stem cell treatments for pets who are poor candidates for invasive surgery.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
The Spine Center
The Spine Center providing excellence in the care and treatment of patients with musculus skeletal disorders.
Viking Therapeutics
Viking Therapeutics is developing novel therapeutics for patients suffering from metabolic and endocrine disorders.
Current Advisors List
Current Employees Featured
Founder
Investors List
Suvretta Capital Management
Suvretta Capital Management investment in Series A - HemoShear Therapeutics
Adage Capital Management
Adage Capital Management investment in Series A - HemoShear Therapeutics
Janus Henderson Investors
Janus Henderson Investors investment in Series A - HemoShear Therapeutics
Jaffray Woodriff
Jaffray Woodriff investment in Series C - HemoShear Therapeutics
Small Business Innovation Research
Small Business Innovation Research investment in Grant - HemoShear Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2022-08-25 | HemoShear Therapeutics Appoints Brian Wamhoff, PhD, Interim Chief Executive Officer |
| 2021-12-14 | HemoShear Therapeutics Appoints Patrick Horn, MD, PhD, Chief Medical Officer |
Official Site Inspections
http://www.hemoshear.com Semrush global rank: 8.19 M Semrush visits lastest month: 354
- Host name: a2aa9ff50de748dbe.awsglobalaccelerator.com
- IP address: 15.197.148.33
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
